fda glp-1 compounding crackdown september 2025 BREAKING NEWS in the space 🚨 is at it again saying they're going to take action limiting access to the active ingredients used to make the compounded medications. Watch FDA Intensifies Crackdown on GLP-1

Ichijo H, Nshida E, Irie K, ten Dijke P, Saitoh M, Moriguchi T, Takagi M, Matsumoto K, Miyazono K and Gotoh Y

Swirl gently: Let the powder fully dissolve

The FDA says pharmacies should not use semaglutide salts such as semaglutide sodium or semaglutide acetate

Visual indicators include color change (from blue to green, brown, or cloudy), visible particles or precipitation, and unusual film or residue

Metabolic health, cardiovascular resilience, cognitive function, and long-term protection against neurodegeneration are all plausibly within reach of a therapeutic strategy that addresses both the hormonal and metabolic dimensions of the menopausal transition simultaneously